Human Papillomavirus (HPV) Infection in Women Participating in Cervical Cancer Screening from 2006 to 2010 in Shenzhen City, South China

  • Wang, Yue-Yun (Shenzhen Maternity and Child Health Hospitals) ;
  • Li, Li (Department of Epidemiology and Statistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology) ;
  • Wei, Sheng (Department of Epidemiology and Statistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology) ;
  • Peng, Ji (Chronic Disease Control Center in Shenzhen) ;
  • Yuan, Shi-Xin (Shenzhen Maternity and Child Health Hospitals) ;
  • Xie, Jian-Sheng (Shenzhen Maternity and Child Health Hospitals) ;
  • Liu, Zhi-Hua (Shenzhen Maternity and Child Health Hospitals)
  • Published : 2013.12.31


Purpose: Human papillomavirus (HPV) infection plays an important role in the development of cervical cancer, but the prevalence of HPV infection in women of Shenzhen city remains unclear. The present study was performed to describe the change of cervical HPV infection in females who participated in voluntary cervical cancer screening from 2006 to 2010 in Shenzhen city, China. Methods: A total of 4, 413 women were recruited. HPV infections were genotyped by polymerase chain reaction (PCR) and reversed dot blot hybridization in Shenzhen Maternity and Child Health Hospital. Results: The prevalence of HPV infection was 13.8%. The five most commonly found HPV types were HPV16 (3.47%), HPV58 (1.68%), HPV33 (1.38%), HPV43 (1.36%) and HPV18 (1.27%). The secular trends of major HPV type-specific were diverse. Among of them, the prevalence of HPV18 increased sharply while others increased slowly or even decreased in the period. The change of total HPV, single HPV and multiple HPV infection were similar during the five years. Conclusions: Our findings suggested that HPV infection is common with HPV16 and HPV 58 as the primary subtypes in women in Shenzhen city.The prevalence of HPV 18 infection is increasing faster than any others, which will lead it to be one of the main subtypes in this city in the future.


  1. Bao YP, Li N, Smith JS, et al (2008). Human papillomavirus type distribution in women from Asia: a meta-analysis. Int J Gynecol Cancer, 18, 71-9.
  2. Bao YP, Li N, Wang H, et al (2007). Study on the distribution of human papillomavirus types in cervix among Chinese women: a meta-analysis. Zhonghua Liu Xing Bing Xue Za Zhi, 28, 941-6 (in Chinese).
  3. Bernard E, Pons-Salort M, Favre M, et al (2013). Comparing human papillomavirus prevalences in women with normal cytology or invasive cervical cancer to rank genotypes according to their oncogenic potential: a meta-analysis of observational studies. BMC Infect Dis, 13, 373.
  4. Bosch FX, Sanjose S (2003). Chapter 1: Human papillomavirus and cervical cancer--burden and assessment of causality. J Natl Cancer Inst Monogr, 31, 3-13.
  5. Bosch FX, Lorincz A, Munoz N, et al (2002). The causal relation between human papillomavirus and cervical cancer. J Clin Pathol, 55, 244-65.
  6. Bosch FX, Manos MM, Munoz N, et al (1995). Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst, 87, 796-802.
  7. Carter JJ, Koutsky LA, Hughes JP, et al (2000). Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis, 181, 1911-9.
  8. Cavalcanti SM, Deus FC, Zardo LG, et al (1996). Human papillomavirus infection and cervical cancer in Brazil: a retrospective study. Mem Inst Oswaldo Cruz, 91, 433-40.
  9. Chaturvedi AK, Katki HA, Hildesheim A, et al (2011). Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease. J Infect Dis, 203, 910-20.
  10. Cibas ES, Hong X, Crum CP, Feldman S (2007). Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples. Gynecol Oncol, 104, 702-6.
  11. Clifford G, Franceschi S, Diaz M, et al (2006). Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine, 24, S3/26-34.
  12. Clifford GM, Smith JS, Aguado T, et al (2003). Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer, 89, 101-5.
  13. Datta P, Bhatla N, Dar L, et al (2010). Prevalence of human papillomavirus infection among young women in North India. Cancer Epidemiol, 34, 157-61.
  14. Einstein MH, Goldberg G L (2002). Human papillomavirus and cervical neoplasia. Cancer Invest, 20, 1080-5.
  15. Figueroa JP, Ward E, Luthi TE, et al (1995). Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity. Sex Transm Dis, 22, 114-8.
  16. Garland S, Park SN, Ngan HY, et al (2008). The need for public education on HPV and cervical cancer prevention in Asia. Opinions of experts at the AOGIN conference. Vaccine, 26, 5435-40.
  17. Guido M, Tinelli A, De Donno A, et al (2013). Prevalence and distribution of human papillomavirus genotype in south eastern Italy, in the period 2006-2011: implications for intervention. Curr Pharm Des, 19, 1498-507.
  18. Hibbitts S, Jones J, Powell N, et al (2008). Human papillomavirus prevalence in women attending routine cervical screening in South Wales, UK: a cross-sectional study. Br J Cancer, 99, 1929-33.
  19. Hwang TS, Jeong JK, Park M, et al (2003). Detection and typing of HPV genotypes in various cervical lesions by HPV oligonucleotide microarray. Gynecol Oncol, 90, 51-6.
  20. Liu M, Wang CX, Deng XM, et al (2007). Study on the genotyping of human papillomavirus using a new DNA liquid chip in women of high-risk group of Shandong province. Zhonghua Liu Xing Bing Xue Za Zhi, 28, 487-90 (in Chinese).
  21. Mejlhede N, Bonde J, Fomsgaard A,et al (2009). High frequency of multiple HPV types in cervical specimens from Danish women. APMIS, 117, 108-14.
  22. Munoz N, Bosch FX, de Sanjose S, et al (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med, 348, 518-27.
  23. Nielsen A, Kjaer SK, Munk C, et al (2008). Type-specific HPV infection and multiple HPV types: prevalence and risk factor profile in nearly 12,000 younger and older Danish women. Sex Transm Dis, 35, 276-82.
  24. Oh JK, Franceschi S, Kim BK, et al (2009). Prevalence of human papillomavirus and Chlamydia trachomatis infection among women attending cervical cancer screening in the Republic of Korea. Eur J Cancer Prev, 18, 56-61.
  25. Smith JS, Lindsay L, Hoots B, et al (2007). Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer, 121, 621-32.
  26. Walboomers JM, Jacobs MV, Manos MM, et al (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189, 12-9.<12::AID-PATH431>3.0.CO;2-F
  27. Wang CH, Garvilles RG, Chen C Y,et al (2010). Characterization of human papillomavirus infection in north Taiwan. J Med Virol, 82, 1416-23.
  28. Wright TC Jr, Denny L, Kuhn L, Pollack A, Lorincz A (2000). HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA, 283, 81-6.
  29. Wu EQ, Liu B, Cui JF, et al (2013). Prevalence of type-specific human papillomavirus and pap results in Chinese women: a multi-center, population-based cross-sectional study. Cancer Causes Control, 24, 795-803.
  30. Wu Y, Chen Y, Li L, et al (2006). Associations of high-risk HPV types and viral load with cervical cancer in China. J Clin Virol, 35, 264-9.
  31. Hausen H, (1996). Papillomavirus infections--a major cause of human cancers. Biochim Biophys Acta, 1288, F55-78.

Cited by

  1. Immune and Anti-oxidant Functions of Ethanol Extracts of Scutellaria baicalensis Georgi in Mice Bearing U14 Cervical Cancers vol.15, pp.10, 2014,
  2. Genotype Distribution of Human Papillomavirus in Women with Abnormal Cervical Cytology in an Esophageal Carcinoma High Incidence Area of China vol.15, pp.12, 2014,
  3. Expression of Toll-like Receptor 9 Increases with Progression of Cervical Neoplasia in Tunisian Women - A Comparative Analysis of Condyloma, Cervical Intraepithelial Neoplasia and Invasive Carcinoma vol.15, pp.15, 2014,
  4. Development of In-House Multiplex Real Time PCR for Human Papillomavirus Genotyping in Iranian Women with Cervical Cancer and Cervical Intraepithelial Neoplasia vol.15, pp.15, 2014,
  5. Preliminary Evaluation of the in vitro Efficacy of 1, 2-di (Quinazolin-4-yl) Diselane against SiHa Cervical Cancer Cells vol.15, pp.15, 2014,
  6. C13orf18 and C1orf166 (MULAN) DNA Genes Methylation are Not Associated with Cervical Cancer and Precancerous Lesions of Human Papillomavirus Genotypes in Iranian Women vol.15, pp.16, 2014,
  7. Type-specific Prevalence of Human Papillomavirus by Cervical Cytology among Women in Brasov, Romania vol.15, pp.16, 2014,
  8. Prevalence and Genotype Distribution of Human Papillomavirus among Women from Henan, China vol.15, pp.17, 2014,
  9. Investigation of Transition Types of HPV DNA Test Results over Time in Korean Women vol.16, pp.8, 2015,
  10. Update knowledge on cervical cancer incidence and prevalence in Asia vol.16, pp.9, 2015,
  11. Association of human papillomavirus type 58 with breast cancer in shaanxi province of China vol.87, pp.6, 2015,
  12. Prevalence and genotype distribution of human papillomavirus: implications for cancer screening and vaccination in Henan province, China vol.49, pp.2, 2016,
  13. Microbial infection, inflammation and epithelial ovarian cancer vol.14, pp.2, 2017,
  14. Estimating the burden of genital warts in Taiwan vol.14, pp.6, 2017,